Aerospace company tapped for mission for new spacewalk, moonwalk system

in the works

NASA has issued another grant to Collins Aerospace to design the future of spacewalks and moonwalks. Image via NASA

Charlotte, North Carolina-based Collins Aerospace has been selected by NASA to develop a spacewalking system for the astronauts aboard the International Space Station.

The award, which is the second under NASA’s Exploration EVA Services contract, has a base value of $97.2 million, per a Dec. 8 news release from NASA. The company has until January 2024 "to complete a critical design review and demonstrate use of the suit on Earth in a simulated space environment," according to NASA, which will then decide the option to extend the contract for testing to be conducted by April 2026.

NASA’s Johnson Space Center in Houston manages the spacesuit contract. Collins Aerospace has had a presence in Houston for 40 years, and recently cut the ribbon on a $30 million facility near the JSC.

“We look forward to obtaining another much-needed service under our contract,” says Lara Kearney, manager of the Extravehicular Activity and Human Surface Mobility Program at JSC, in the release. “By working with industry, NASA is able to continue its over 22-year legacy of maintaining a presence in low-Earth orbit.”

The current system was designed decades ago and has been used during previous space shuttle and space station missions. Collins Aerospace will work with Houston-based Axiom Space on this project, which was initially announced this summer.

"Both vendors will continue to compete for future task orders which include recurring services for station spacewalks and moonwalks beyond Artemis III," the news release reads.

Axiom Space will outfit our astronauts. Photo courtesy of NASA

Houston tech company lands exclusive spacesuit deal for NASA's mission to moon

suit up

When astronauts make a historic return to the surface of the moon, presumably 2025 or 2026, they’ll don Houston-crafted, life-protecting suits.

Houston-based Axiom Space has landed the rights to create spacesuits and supporting systems for NASA’s Artemis III mission, which will see humans back on our satellite for the first time since the legendary Apollo missions more than 50 years ago.

This award is the first for a competitive spacesuits contract, NASA notes in a press release. NASA tapped Axiom Space for a task order boasting a base value of $228.5 million. As previously reported, Axiom Space was one of two companies NASA pegged for spacesuit and supporting system development.

These new suits are pivotal, as plans for NASA’s Artemis lunar program call for not just lunar orbit, but trips to the lunar south pole and even a crewed outpost on the moon.

Axiom Space will be responsible for the design, development, qualification, certification, and production of its spacesuits and support equipment. Spacesuits will be tested for moonwalks and spacewalks.

This spacesuit contract, which will advance spacewalking capabilities in low-Earth orbit and on the Moon, is managed by the Extravehicular Activity and Human Surface Mobility Program (EHP) at Johnson Space Center.

“NASA is proud to partner with commercial industry on this historic mission that will kickstart the United States building a lasting presence on the surface of the Moon,” said Lara Kearney, manager of NASA’s Extravehicular Activity and Human Surface Mobility program. “What we learn on Artemis III and future missions on and around the Moon will pave the way for missions to Mars. Spacesuits enable us to literally take that next step.”

The first lunar mission since 1972, Artemis will be historic in myriad ways, none of least for seeing the first woman and the first person of color on the moon, as well as a testing ground for eventual Mars missions.

Artemis I is set to launch on September 19, barring any delays.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Axiom Space officially redomiciles its headquarters in Texas

space city

Axiom Space has claimed Houston as its operational home since 2016. And now it can call Texas its official legal headquarters, too.

The spacetech company, which is developing the first commercial space station, Axiom Station, has officially redomiciled its legal headquarters from Delaware to Texas, Axiom announced this week.

Axiom employs approximately 700 people, the majority of whom are in Texas, according to a news release. Its Assembly Integration and Test Facility was built as an anchor of the Houston Spaceport, and the company is also developing next-generation spacesuits at its Houston-based spacesuit lab.

“Texas has demonstrated, consistently and deliberately, that it wants innovative companies to thrive here and has built the policy and regulatory framework accordingly,” Jonathan Cirtain, CEO and president of Axiom Space, said in the release. “For Axiom Space, establishing Texas as both our operational and legal home puts us squarely in a state that understands our mission, supports our industry, and shares in what we are working to achieve.”

Axiom touts Texas's "financial and infrastructural commitments" to the space economy as reasons for the move, including programs and grants from organizations such as the Texas Space Exploration & Aeronautics Research Fund (SEARF), the Texas Space Commission, and the Texas A&M Space Institute.

Axiom was previously awarded a $5.5 million SEARF grant for the development of its orbital data center capabilities last year.

The news comes as energy giant ExxonMobil also announced concrete plans to redomicile its legal headquarters in Texas. Exxon's board of directors unanimously recommended redomiciling in the Lone Star State in March. The company announced this week that the move would become official July 1. The company's operational headquarters is based in Spring, Texas, a Houston-area suburb.

Houston cleantech, space startups named to World Economic Forum cohort

top honor

Two Houston-based startups have been selected to join the World Economic Forum's Technology Pioneers community.

The two-year program aims to help mission-driven, early-stage start-ups scale their innovations through multi-stakeholder initiatives, co-creating partnerships and other gatherings for community members. One-hundred startups are selected each year from around the globe, this year hailing from 23 countries and working in AI, energy, space, biotech markets and more.

Cleantech startup Vaulted Deep was one of 11 energy and climate companies to be named to the cohort. Julia Reichelstein and Omar Abou-Sayed founded the company in 2023. Its technology injects excess organic waste underground to remove carbon dioxide from the atmosphere.

Last year, Vaulted Deep inked a 12-year deal with Microsoft to remove up to 4.9 million metric tons of carbon dioxide from the environment.

The startup has earned several accolades in recent years, including a No. 3 spot on Fast Company’s list of the World’s Most Innovative Companies of 2026. It was also recently named to market intelligence and advisory firm Cleantech Group's annual Global Cleantech 100 list for a second year in a row.

"Waste management is one of the world's great invisible infrastructure systems ... The need for new infrastructure is growing as disposal challenges become more complex and regulations evolve. Vaulted is building the first new disposal pathway for organic waste in decades by putting it deep underground, permanently," the company shared in a LinkedIn post. "This year, we're joining the World Economic Forum's 2026 Tech Pioneers alongside innovators working on the many interconnected challenges shaping our future."

Houston-based Venus Aerospace was also selected to join the cohort, along with six other spacetech companies. The company was founded in 2020 by Sassie and Andrew Duggleby.

The startup specializes in next-generation rocket engine propulsion as a cleaner alternative to traditional combustion engines. The company's rotating detonation rocket engine (RDRE) burns fuel more efficiently and completed a successful high-thrust test flight last year. Venus says it’s the only company in the world that makes a flight-proven, high-thrust RDRE with a “clear path to scaled production.”

"Frontier technologies matter most when they expand what people, industries, and nations can do," Sassie Duggleby, co-founder and CEO of Venus, said in a news release. "For Venus, RDRE does not just represent a more efficient engine. It is a foundation for faster movement, more capable space systems, and new forms of connectivity across the planet. Being named a Technology Pioneer validates the potential of this technology to help shape a future where distance is less limiting."

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston Methodist receives record $110M gift, names future tower

historic gift

Houston Methodist has received the largest gift in the health system's history to establish new funds for neurological, neuroscience, and women’s health research and treatment.

The $110 million gift comes from Houston-based The Brockman Medical Research Foundation, which supports education and research in the science, medicine and healthcare fields. In response, Houston Methodist announced that it will name its forthcoming 26-story hospital facility the Brockman Centennial Tower.

The tower’s entrance will be named the Anna Margaret Bellows Centennial Hall to honor Anna Margaret Bellows, a young camper who died during the Camp Mystic flooding last summer.

“This extraordinary gift accelerates discovery and transforms how care is delivered,” Dr. Marc Boom, president and CEO of Houston Methodist, said in a news release. “We are grateful to The Brockman Medical Research Foundation for its incredible generosity and vision that will help change the lives of generations of patients. Naming Centennial Tower in recognition of this gift reflects the scale of this commitment and its impact on the future of neuroscience, neurological care and women’s health.”

The gift will be divided into two parts:

  • $100 million will go toward creating an innovation fund within the Houston Methodist Academic Institute and the Houston Methodist Neurological Institute
  • $10 million will be devoted to Houston Methodist's Department of Obstetrics and Gynecology

“This tremendous gift will accelerate translational research that broadens our understanding of neurological and other diseases,” Dr. Jenny Chang, president and CEO of the Houston Methodist Academic Institute, added in the release. “It will allow us to leverage state-of-the-art platforms to detect, diagnose and deliver therapeutics, keeping patient care at the center of our mission.”

The Brockman Centennial Tower is expected to open next year in the Texas Medical Center. Spanning more than 1 million square feet, it will house 400 patient beds, an expanded emergency department, new operating rooms and a rooftop garden. It will be connected to Houston Methodist's flagship Paula and Joseph C. “Rusty” Walter III Tower, which opened in 2018. The Centennial Tower was estimated to cost $1.4 billion when announced in 2022.

In addition to the news of the Brockman gift, Houston Methodist also announced this month that it has launched the Houston Methodist Center for Cell and Gene Therapy and tapped an internationally recognized scientist as its leader.

The new center is focused on discovering and developing innovative and cost-effective therapies for a variety of congenital and acquired diseases, including cancer, HIV and cardiovascular disease.

Dr. Malcolm Brenner has been named as the center's inaugural leader and will assume the role starting in October. He will work alongside scientists and support staff from Baylor College of Medicine and Texas Children's Hospital.

Brenner is a professor of pediatrics, medicine, molecular and human genetics and translational biology at Baylor College of Medicine. He is known for making early advances in using bone marrow transplantation as a form of cell therapy and in engineered immune-cell treatments for cancer and infections, according to a release from Houston Methodist.

“Malcolm Brenner is a pioneer in the field of cell and gene therapy and is uniquely qualified to lead Houston Methodist’s research efforts in this field,” Chang added. “His vision and leadership will play a pivotal role in advancing our work in this space.”

View All Listings